Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Enliven Therapeutics Provides Corporate Update On Financing, Expansion Of Board And Leadership Team

PUBLIC · ELVNJan 19, 2022•over 4 years ago

Round Type

Funding Round

BoulderBiotechnologyHealthcareHealth CareScience And EngineeringTherapeutics

Description

Enliven Therapeutics, Inc. ("Enliven" or the "Company"), a precision oncology company focused on the discovery and development of next-generation small molecule kinase inhibitors, today provided a corporate update on the close of an $85 million Series B financing, additions to the Board of Directors, and expansion of the Company's leadership team.

Company Information

Company

Enliven Therapeutics

Location

Boulder, Colorado, United States

About

Enliven Therapeutics is a biopharmaceutical company focused on the discovery and development of small molecule inhibitors to help patients with cancer live not only longer, but better. Enliven aims to address existing and emerging unmet needs with a precision oncology approach that improves survival and enhances overall patient well-being. Enliven’s discovery process combines deep insights from clinically validated biological targets and differentiated chemistry to design potentially first-in-class or best-in-class therapies.

Don't miss Enliven Therapeutics's next move

Get an email the moment Enliven Therapeutics raises, hires an exec, or expands — usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
1 contact
Verified contacts17 people are listed at Enliven Therapeutics — we don't have their email yet.
Predictive Intelligence
Strategic

ML-powered predictions for Enliven Therapeutics's next move

Learn about Strategic plan

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.